These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39236066)

  • 41. SETD2 indicates favourable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion.
    Chen Z; Raghoonundun C; Chen W; Zhang Y; Tang W; Fan X; Shi X
    Biochem Biophys Res Commun; 2018 Apr; 498(3):579-585. PubMed ID: 29522714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN.
    Meng L; Chen Z; Jiang Z; Huang T; Hu J; Luo P; Zhang H; Huang M; Huang L; Chen Y; Lu M; Xu AM; Ying S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):49-57. PubMed ID: 31828293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells.
    Lu H; Feng Y; Hu Y; Guo Y; Liu Y; Mao Q; Xue W
    J Cell Mol Med; 2020 Jan; 24(1):98-113. PubMed ID: 31691494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
    Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
    Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RUNX1, FUS, and ELAVL1-induced circPTPN22 promote gastric cancer cell proliferation, migration, and invasion through miR-6788-5p/PAK1 axis-mediated autophagy.
    Ma S; Xu Y; Qin X; Tao M; Gu X; Shen L; Chen Y; Zheng M; Qin S; Wu G; Ju S
    Cell Mol Biol Lett; 2024 Jul; 29(1):95. PubMed ID: 38956466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GNA13 as a prognostic factor and mediator of gastric cancer progression.
    Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
    Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
    Xu Y; Feng Y; Sun Z; Li Q
    Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer.
    Xiong W; Deng Z; Tang Y; Deng Z; Li M
    Biochem Biophys Res Commun; 2018 Sep; 504(1):129-136. PubMed ID: 30177394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation.
    Yang M; Li Q; Yang H; Li Y; Lu L; Wu X; Liu Y; Li W; Shen J; Xiao Z; Zhao Y; Du F; Chen Y; Deng S; Cho CH; Li X; Li M
    Biomed Pharmacother; 2024 Apr; 173():116336. PubMed ID: 38412717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.
    Liang R; Chen W; Chen XY; Fan HN; Zhang J; Zhu JS
    Pathol Res Pract; 2021 Feb; 218():153318. PubMed ID: 33370709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA LOC285194 modulates gastric carcinoma progression through activating Wnt/β-catenin signaling pathway.
    Zhong B; Wang Q; He J; Xiong Y; Cao J
    Cancer Med; 2020 Mar; 9(6):2181-2189. PubMed ID: 31991056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway.
    Du T; Qu Y; Li J; Li H; Su L; Zhou Q; Yan M; Li C; Zhu Z; Liu B
    Mol Cancer; 2014 May; 13():100. PubMed ID: 24885567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.
    Zhang J; Zhang K; Hou Y
    Mol Med Rep; 2020 Aug; 22(2):687-696. PubMed ID: 32468065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EIF4A3-Bound hsa_circ_0006847 Exerts a Tumor-Suppressive Role in Gastric Cancer.
    Cao C; Wu X; Li Z; Xie Y; Xu S; Guo J; Sun W
    DNA Cell Biol; 2024 May; 43(5):232-244. PubMed ID: 38513058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Liu S; Lin C; Lin X; Lin P; He R; Pan X; Lin Y; Ye J; Zhu G
    Cancer Res; 2024 Oct; 84(19):3207-3222. PubMed ID: 39024555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.